MARKET

PRPH

PRPH

Prophase Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.16
+0.10
+1.98%
Closed 16:00 09/23 EDT
OPEN
5.09
PREV CLOSE
5.06
HIGH
5.25
LOW
5.07
VOLUME
42.06K
TURNOVER
--
52 WEEK HIGH
16.04
52 WEEK LOW
3.097
MARKET CAP
78.20M
P/E (TTM)
-30.2108
1D
5D
1M
3M
1Y
5Y
ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference
GARDEN CITY, NY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Benzinga Healthcare Small Cap Conference, which is bein...
GlobeNewswire · 2d ago
BRIEF-Prophase Labs Announces $6 Mln Stock Repurchase Program
reuters.com · 09/08 13:04
ProPhase Labs Announces $6 Million Stock Repurchase Program
ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announced that its Board of Directors has authorized the repurchase of up to $6 million in ProPhase common stock.
GlobeNewswire · 09/08 12:30
ProPhase Labs Sets Up $6 Million Share Buyback Plan
MT Newswires · 09/08 09:50
ProPhase Labs to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the H.C. Wainwright 23 Annual Global Investment Conference, which is being held virtually from September 13 - 1...
GlobeNewswire · 09/07 12:30
Perritt Capital Management Inc Buys Bowman Consulting Group, ProPhase Labs Inc, Orbital Energy ...
GuruFocus News · 08/17 19:38
ProPhase Labs to Present at Two Upcoming August Conferences
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to present at the following investor conferences: Q3 Investor S...
GlobeNewswire · 08/16 12:30
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor au...
ACCESSWIRE · 08/16 12:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRPH. Analyze the recent business situations of Prophase Lab through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRPH stock price target is 14.50 with a high estimate of 20.00 and a low estimate of 9.00.
EPS
Institutional Holdings
Institutions: 28
Institutional Holdings: 1.64M
% Owned: 10.84%
Shares Outstanding: 15.15M
TypeInstitutionsShares
Increased
10
660.58K
New
3
42.99K
Decreased
9
100.09K
Sold Out
9
294.56K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
+0.88%
Food & Tobacco
+0.89%
Key Executives
Chairman/Chief Executive Officer/Director
Ted Karkus
Chief Financial Officer
Monica Brady
Independent Director
Jason Barr
Independent Director
Louis Gleckel
Independent Director
Warren Hirsch
Declaration Date
Dividend Per Share
Ex-Div Date
05/13/2021
Special Dividend USD 0.3
05/24/2021
11/20/2019
Dividend USD 0.25
12/02/2019
11/20/2019
Special Dividend USD 0.25
12/02/2019
12/26/2018
Dividend USD 0
01/09/2019
12/26/2018
Special Dividend USD 0.25
01/09/2019
05/07/2018
Dividend USD 0
06/06/2018
05/07/2018
Special Dividend USD 1
06/06/2018
About PRPH
ProPhase Labs, Inc. is a medical science and technology company. The Company operates through two segments: consumer products and diagnostic services. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. The diagnostic services segment provides COVID-19 diagnostic information services to a range of customers in the United States, including health plans, third party payers and government organizations. The Company is also engaged in development and distribution of a product line of OTC dietary supplements under the brand name of TK Supplements. The TK Supplements product line offers two men’s health products, including Legendz XL for sexual health and Triple Edge XL, an energy booster plus testosterone support.

Webull offers kinds of ProPhase Labs Inc stock information, including NASDAQ:PRPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRPH stock methods without spending real money on the virtual paper trading platform.